• No se han encontrado resultados

[PDF] Top 20 Module XlXCost efficacy and costbenefit of treatment of hepatitis C

Has 10000 "Module XlXCost efficacy and costbenefit of treatment of hepatitis C" found on our website. Below are the top 20 most common "Module XlXCost efficacy and costbenefit of treatment of hepatitis C".

Module XlXCost efficacy and costbenefit of treatment of hepatitis C

Module XlXCost efficacy and costbenefit of treatment of hepatitis C

... Siebert and Sroc- zynsky as part of the German team for hepatitis C mod- el (GEHMO), as commissioner of Federal Germany Health and Social Security ...review of published ... See full document

5

Safety and efficacy of treatment with pegylated interferon alpha 2a with ribavirin in chronic hepatitis C genotype 4

Safety and efficacy of treatment with pegylated interferon alpha 2a with ribavirin in chronic hepatitis C genotype 4

... interferon treatment and high degree of sequence variability of hypervariable region are indicati- ve of poor response to interferon treatment in patients with chronic ... See full document

6

Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals

Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals

... chronic hepatitis C while fatigue decreases in a similar manner as younger ...antiviral treatment, however frailty, comorbidities and associated treatments should be care- fully ...The ... See full document

10

Efficacy and safety of interferon based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit

Efficacy and safety of interferon based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit

... Limitations of this study are the small number of group B patients, as well as the fact that 9/19 of them were interferon experienced but their SVR to peg-IFN was not statistically different from ... See full document

7

Treatment of chronic hepatitis C virus infection in the near future

Treatment of chronic hepatitis C virus infection in the near future

... Treatment of chronic HCV infection has a remar- kable history of success almost without parallel in the field of ...antiviral treatment. Current- ly, the standard of care for HCV ... See full document

6

New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C

New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C

... the treatment duration beyond 48 weeks is one strategy that may improve response rates in these difficult-to-treat pa- ...time of HCV-RNA negativity, especially in patients with a slow viral decline (first ... See full document

8

Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta Analysis

Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta Analysis

... Background and aim. The combination of Sofosbuvir (SOF) and Ledipasvir (LDV) has been lead to considerable enhancement of treatment of hepatitis C virus (HCV) ... See full document

10

History and progress of antiviral drugs: from acyclovir
to direct acting antiviral agents (DAAs) for Hepatitis C

History and progress of antiviral drugs: from acyclovir to direct acting antiviral agents (DAAs) for Hepatitis C

... decade of poorly effective HCV therapy, the development of specific compounds against this virus ramped up HCV treatment on a pace that nearly matched antiretroviral therapy for ...systems and ... See full document

10

Meta Analysis of Grazoprevir plus Elbasvir for Treatment of Hepatitis C Virus Genotype 1 Infection

Meta Analysis of Grazoprevir plus Elbasvir for Treatment of Hepatitis C Virus Genotype 1 Infection

... elbasvir and ribavirin regimen vs. grazoprevir and elbasvir without ribavirin in the treatment of hepatitis C virus genotype 1 infection and to precisely evaluate the ... See full document

15

An open, non-controlled clinical study to assess the efficacy and safety of the recombinant human alpha 2b pegylated interferon PEG-Heberon plus ribavirin for the treatment of chronic hepatitis C virus infection in Cuban patients

An open, non-controlled clinical study to assess the efficacy and safety of the recombinant human alpha 2b pegylated interferon PEG-Heberon plus ribavirin for the treatment of chronic hepatitis C virus infection in Cuban patients

... dard treatment in patients with chronic HCV infection for more than a decade ...inhibitors and polymerase inhibitors, which when added to the standard treatment, show better efficacy, ... See full document

7

Module VPredictive factors for response to treatment of chronic hepatitis C

Module VPredictive factors for response to treatment of chronic hepatitis C

... the efficacy of treatment with inter- ...progression of chronic hepatitis C, increasing the necroinflammatory component and the grade of ...induction of ... See full document

5

Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin stimulated peripheral blood mononuclear cells  (Inhibitory effects of ribavirin on cytokine production)

Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin stimulated peripheral blood mononuclear cells (Inhibitory effects of ribavirin on cytokine production)

... Although the mechanism by which the drug exerts its response on patients with chronic HCV infection is un- der evaluation, there is evidence that ribavirin is likely to have immunomodulatory and anti-inflammatory ... See full document

5

Ayurveda medicine for the treatment of Parkinson's disease

Ayurveda medicine for the treatment of Parkinson's disease

... effect of MP on parkinsonism could be confounded by many ...16% of PD patients undergoing clinical trials can show a 50% improvement in parkinsonism while on a placebo ...number of other important ... See full document

7

Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy

Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy

... Background and aims. Practitioners treating hepatitis C (HCV) provide healthcare to a special population with high rates of substance abuse and psychiatric ...patients and tested ... See full document

9

Inter and intrapatient evolution of hepatitis C virus

Inter and intrapatient evolution of hepatitis C virus

... Hepatitis C virus (HCV) has a short replication time, high mutation rates and large population sizes, all of which make it an excellent experimental model for evolution studies, because ... See full document

8

Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C

Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C

... mentation of the multidisciplinary team, hepatologists and nurses provided specific support to patients receiv- ing antiviral treatment, and patients had access to nurses, to a hotline, ... See full document

8

Safety and Efficacy of the Newer Biological Therapeutics in the Treatment of Rheumatoid Arthritis

Safety and Efficacy of the Newer Biological Therapeutics in the Treatment of Rheumatoid Arthritis

... clones of a unique parent ...means of the neutralization of a cytokine, blockade of the co-stimulatory molecules and induc- ing cytolysis, apoptosis or depletion of molecules in ... See full document

9

Evolution of hepatitis B virus during long term therapy in patients with chronic hepatitis B

Evolution of hepatitis B virus during long term therapy in patients with chronic hepatitis B

... product of 486-bp was visible after aga- rose gel electrophoresis and was purified (Qiagen “QIAquick® PCR Purification kit”) prior to cycle sequencing with a BigDye terminator ...Biosystems) and an ... See full document

7

Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment

Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment

... The treatment for genotype 1 chronic hepatitis C infection is rapidly ...pegIFN and RBV are the new standard of ...effect of these drugs reduces the strength of the ... See full document

11

Autoeficacia y vivencias académicas en estudiantes universitarios

Autoeficacia y vivencias académicas en estudiantes universitarios

... men) of four Southern Chilean universities, specifically in the city of Concepción, whose ages ranged between 18 and 29 years old, with an average of ...report of different aspects ... See full document

9

Show all 10000 documents...